Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...
a class of drug that effectively reduces cholesterol. Guidelines for doctors do not recommend prescribing statins to diabetic patients unless they have high cholesterol levels. But the new ...
Overall, a 20% decrease in LDL cholesterol was seen. Participants reported that they would have found more information on drug interactions ... make statins unavailable to non-insured or indigent ...
Tony Gotto, from the Weill Cornell Medical College in New York ... candidates for statin therapy. So even though participants had what is currently considered to be normal cholesterol or LDL ...
A UCLA study has outlined a new framework that researchers say would improve predictive power ... Researchers analyzed how their genetic makeups impacted their response to four of the most commonly ...
Women who have had a stroke may be less likely than men to take medications to prevent a second stroke, with Mexican American women reporting the highest rates of nonadherence, according to new ...